HealthNews

Kotak Securities

New Delhi. India’s publicly listed hospitals will likely maintain double-digit revenue increases, even as EBITDA is range-bound by a bed-additions-driven cycle. Kotak Securities

The brokerage expects the top-line to continue growing, citing ARPOB increases of 6-14% YoY across most hospitals, strong Inpatient Department volumes, and B2C diagnostics traction. Kotak said that the March quarter was a “fine quarter”. The hospitals have seen a growth of 18% year-on-year in their sales, and a growth of 16% for EBITDA. ARPOB was up 6-14% YoY in most hospitals. This growth was attributed to the reduction in ALOS as well as a better specialty mix. KIMS recorded a YoY ARPOB increase of 14 percent, largely driven by high-ARPOB cities like Thane or Bengaluru. According to a Kotak Securities report, Medanta’s ARPOB increased 6 percent YoY, despite its new Noida facility, due to lower ALOS, and a more complex case mix. ollo Hospitals’ ARPP grew by 9 percent YoY due to a better case mix and pricing, plus 7% YoY growth in IP volume. IPD footfalls grew 7-30 per cent YoY for most players, except Narayana Hrudayalaya and Max. Max Healthcare is the exception with a 1% ARPOB YoY growth. This was due to discontinuation of expensive chemo drugs used by CGHS patients, and GST rate cut. Oncology’s sales share dropped from 26 to 21 percent a year ago. Max’s gross revenue still increased by 15% YoY, even if you exclude oncology. The new beds had a negative impact on profitability. Except for HS & Narayana Hrudayalaya all hospitals increased operational bed counts by 5-21% YoY. For HS operational beds rose by only 1 percent quarter-over-quarter, while cacity beds jumped by 6 percent. The losses at four new hospitals, Defence Colony Hospital, Kolkata Hospital, Hyderabad Hospital, and Pune, were Rs. 414 Million in 4QFY26 as compared to Rs. 150 Million in 3QFY26. The mature unit EBITDA was 25,5%, up from 24,4% YoY. KIMS and Medanta’s margins were also impacted by Thane/Bengaluru, Noida and Noida unit. KIMS was also affected by delays in insurance empanelment.

Diagnostics in coverage did well. DLPL reported a 15-17 percent YoY growth in organic sales on a 9-13% YoY growth in sample volume and boosted wellness mix. B2C engagement improved when online players cut their discounts. Metropolis’ YoY growth of 23 percent was boosted through the acquisitions of Core, DIC Scientific and Ambika. Diagnostics EBITDA grew by 27 per cent, with margins increasing 175 basis points.

Published on Jun 7, 2026, 12:15 PM (IST)

Join the community and join 2M+ other industry professionals. Subscribe to our Newsletter for the latest industry insights & analyses.

Your smartphone is your portal to ETHealthworld!

HealthNews

PM Modi virtual inaugurates ESICs hospital with 220 beds in Surat.

New Delhi – Prime Minister Narendra Modi inaugurated virtually the Employees’ State Insurance Corporation Hospital in Surat on Friday from the Surat Indoor Stadium. This marked yet another milestone in Government’s efforts to provide quality healthcare to the organized workforce of the nation.

The Director General ESIC and other key employers were present at an event held in the ESIC Hospital. They also watched the live broadcast of Prime Minister Modi’s virtual address. The event was marked by the direct payment of cash benefits to ESI recipients and the felicitation for the construction workers that built the hospital. This reaffirmed the Government’s commitment to dignity and welfare for every worker. The newly opened ESIC Hospital in Surat will provide a lifeline to proximately 3,20 lakh insured persons and 12.16 lakh beneficiaries. It was built on an 8.60-acre site at a cost of Rs. 216 Crore. The hospital, which is strategically located only 20 minutes from Surat Railway Station offers a range of specialties, including General medicine, surgery, Obstetrics & Gynaecology (Ogynecology), Oncology (Psychiatry), Ophthalmology (ENT), and Dental care. Radiology services and pathology services are also available round the clock. The inauguration strengthens Gujarat’s extensive ESI healthcare system, which began in the state in November 1964. Today, it extends its social protection umbrella to around 20,04 lakh insured persons across 34 districts. The government’s commitment to strengthening the Surat healthcare ecosystem is evident in the inauguration of the hospital.

Published on Jun 6, 2026, at 7:40 AM (IST)

Join our community of over 2M industry professionals. Subscribe to the Newsletter to receive latest insights and analysis directly to your inbox.

You can now get all the information about ETHealthworld on your mobile!

HealthNews

Medtronic exceeds quarterly expectations on strong demand for heart devices.

Bengaluru, India: Medtronic surpassed Wall Street estimates in the fourth quarter for revenue and adjusted profits. The company rode a wave of constant demand for its heart device used for complex cardiac procedures. Medtronic has focused on smaller and targeted acquisitions in order to enhance its portfolio after its spin-off of its diabetes business. Medtronics growth levers are its pulsed-field ablation systems and transcatheter valve replacement devices. These two minimally-invasive cardiovascular technologies have seen rid adoption. According to LSEG, the revenue for the fourth quarter was $9.81 billion compared to estimates of $9.63billion. The company’s pulsed field ablation segment, which represents nearly 40% of its sales, saw a 13.8% increase in revenue to $3.8 billion for the fourth quarter. Sales in the company’s neuroscience segment increased 5%, to $2.75 Billion. This was slightly less than analysts’ estimates of $2.76 Billion. Medtronic, on an adjusted basis reported a quarterly profit of 1,55 per share. This was just above the average analyst estimate of 1,54 per share. According to LSEG data, the Dublin, Ireland based company projected adjusted annual profits in the range between $5.90 and $6 per share in fiscal 2027. This is below the $6.06 analysts penciled in. Medtronic reported last quarter it expects to incur a tariff hit of about $300 million in fiscal year 2027. That’s up from roughly $185 million the previous fiscal year. (Reporting and editing by Padmanabhan Ananthan in Bengaluru, Christy Santhosh)

Published on Jun 6, 2026, at 7:31 AM (IST)

Join a community of more than 2 million industry professionals. Subscribe to our Newsletter for the latest industry insights and analysis.

You can now get all the information about ETHealthworld on your mobile!

HealthNews

Manipal Health leases a hospital in Bengaluru for a long time.

Temasek-backed Manipal Health Enterprises, a hospital chain operated by Temasek-backed TPG, has leased a multi-speciality building of 2.45 lakh square feet in Bengaluru’s Yelahanka district. The total rental cost is estimated to be around Rs 816.12 cr over the lease term after factoring scheduled rent increases. The property consists of three basement floors, a first floor and ten upper floors. Manipal Health Enterprises is paying a monthly rent starting at Rs 1,27 crore. This translates into Rs 52 per square foot per month. In connection with the transaction, Manipal Health Enterprises has paid a security of Rs 7.64 billion. In January 2010, the company bought a hospital building in Mumbai’s west suburb Andheri, for Rs. 495 crore. This was one of India’s largest healthcare real-estate transactions of the year. This multi-specialty building, built by JKC Varma & Other in Venkatala near Yelahanka was leased to the healthcare operator under a new lease agreement, for a duration of 29 years and eleven months. These documents were accessed via Propstack, a data platform that analyzes realty. The lease agreement stipulates a 10% rent increase in the sixth-year. Rents will then increase by 15 percent every three years until the end of the lease, which would result in a significant rental increase over the next three decades.

Based upon the initial rent, and the agreed-upon escalation scheme, the total rental expenditure over the 29 years and 11 months lease term comes to about Rs 816.12 Crore. Manipal Health Enterprises is expanding in major Indian cities by acquiring brownfield sites and expanding existing facilities. The ET’s email to Manipal Health Enterprises was not answered until the time of publication. The transaction demonstrates the preference for long-term occupancy by healthcare operators in urban markets. Bengaluru is still experiencing strong demand in the office, residential and healthcare real estate segments. This is due to sustained population and economic growth.

The large-format assets of hospitals are usually leased for a long time due to the substantial investments in medical equipment, fit outs and operational infrastructure. These agreements provide tenants with long-term security and stability in business, while also ensuring a stable rental income for the property owner. The expansion of hospital networks in India, the rise in healthcare demand, and the need for long-term occupancy are driving this sector to grow at a rid rate.

Because hospitals require substantial investments in equipment and fittings, long-term leases are essential for stability. These large-scale transactions also show the convergence between healthcare and realty, as operators are increasingly securing strategic assets in key cities to support their future expansion.

Published on Jun 5, 2026, at 7:46 AM (IST)

Join our community of over 2 million industry professionals. Subscribe to our Newsletter for the latest industry insights & analyses.

You can now get all the information about ETHealthworld on your mobile!

HealthNews

Paras Healthcare files preliminary documents with Sebi in order to raise Rs 1,800 Crore through an Initial Public Offering (IPO)

New Delhi, Paras Healthcare Ltd. which operates hospitals under “Paras Health” brand has filed preliminary perwork with cital market regulator Sebi. Dharminder Kumar Nagar, the promoter of Paras Healthcare Ltd and other investors are selling shares. The Gurugram based company plans to use proceeds from this fresh issue as a prepayment of or repayment of some outstanding borrowings. They will also be investing in their wholly-owned PMHPL subsidiary for debt payments and other corporate purposes. Paras Healthcare, a clinical-specialty-led hospital platform that provides tertiary or quaternary care through an eight-hospital network with a combined cacity of 2,211 bed as of March 31 2026, is a clinically specialty led hospital platform. The company is active in five states and a union territory including Haryana and Bihar. In fiscal 2026, the companys revenue from operation was Rs 1,605.95 billion, while its EBITDA profit (operating income) was Rs 335.58 crore. Paras Healthcare submitted draft IPO pers to Sebi back in 2024, and obtained regulatory proval. However, the company decided not to proceed with its public offering. The book-running lead manager for the issue is JM Financial. BofA Securities India, and Nuvama wealth management are also involved. The proposed listing on BSE and NSE of equity shares. PTI

Published on Jun 5, 2020 at 1:54 PM IST
Join our community of over 2M+ professionals in the industry. Subscribe to our Newsletter for the latest industry insights and analysis.

Your smartphone is your portal to ETHealthworld!

HealthNews

Warburg, KKR and TPG are among the PE giants competing for a 25% stake of Cloudnine.

Mumbai – Global private equity firms Warburg Pincus and KKR as well as TPG Cital and Advent International along with CVC Cital Partners and Permira and homegrown Kedaara Cital have entered the race to buy a 25% stake of Cloudnine – India’s largest maternity hospital and pediatric chain. The people who spoke to us said that the proposed deal would value Cloudnine around Rs10,000 crore ($1billion). Allegro Cital will be running the sales process, with initial bids due by the first week of July. True North, a current investor in the deal, will exit completely. According to the above-mentioned people, Temasek and TPG Newquest will likely retain their stakes.

Temasek, TPG Newquest and Cloudnine collectively hold about 52%. About 10% of Cloudnine is owned by the promoter group, and the rest are employee stock options plans (ESOPs). Cloudnine’s plans for raising $200-300m at a valuation $1 billion were first reported by ET on May 10th. True North entered Cloudnine with a Rs400-crore investment in 2015. Matrix Partners, Sequoia Cital and others have invested in Cloudnine before.

Permira, KKR and their spokespeople declined to comment. True North, Warburg Pincus Kedaara Cital CVC TPG Cital and Advent did not respond to emails. Cloudnine is a Bengaluru based company founded in 2006 by Dr R Kishore Kumar and his co-founders Rohit M.A. M. Ramachandra & Vidy Kumar. People said that the company had a revenue of 2,000 crores and Ebitda at 300 crores in FY26.

Published on Jun 4, 2026 10:57 AM (IST)

Join our community of over 2M+ professionals in the industry. Subscribe to our Newsletter for the latest industry insights and analysis.

You can now get all the information about ETHealthworld on your mobile!